全国服务咨询热线:

18438616290

Products产品中心
首页 > 产品中心 > 生化试剂 > 小分子化合物 > abs810687Anacetrapib 875446-37-0

Anacetrapib 875446-37-0

简要描述:Anacetrapib 875446-37-0
Anacetrapib (MK0859) is a potent, selective, reversible rhCETP and mutant CETP(C13S) inhibitor with IC50 of 7.9 nM and 11.8 nM,

  • 产品型号:abs810687
  • 厂商性质:生产厂家
  • 更新时间:2026-02-06
  • 访  问  量:1326

详细介绍

品牌absinCAS875446-37-0
分子式C30H25F10NO3纯度>98%
分子量637.51货号abs810687
规格10mg供货周期现货
主要用途is a potent, selective应用领域化工,生物产业,农林牧渔,制药/生物制药,综合

Anacetrapib 875446-37-0

产品描述
描述

Anacetrapib (MK0859) is a potent, selective, reversible rhCETP and mutant CETP(C13S) inhibitor with IC50 of 7.9 nM and 11.8 nM, increases HDL-C and decreases LDL-C, does not increase aldosterone or blood pressure. Phase 3.

纯度
>98%
储存/保存方法
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
基本信息
别名
MK-0859, MK 0859, MK0859
外观
Powder
可溶性/溶解性
Ethanol :117 mg/mL (183.5 mM)
DMSO :117 mg/mL (183.5 mM)
生物活性
靶点
rhCETP,Mutant CETP (C13S)
In vitro(体外研究)
Anacetrapib is not only able to increase HDL-cholesterol, but also further decreases LDL-cholesterol when taken in combination with a statin. Anacetrapib dose-dependently and significantly decreases the transfer of CE from HDL3 to HDL2. Anacetrapib doesn't affect the amount of -dalcetrapibthiol bound to rhCETP. Anacetrapib decreases pre-β-HDL formation by more than 46%. Anacetrapib potently blocks CE and TG transfer in 95% human serum.
In vivo(体内研究)
In a dyslipidemic hamster model, 60 mg/kg/day Anacetrapib for 2 weeks results in a 94% reduction in CETP activity and 47% increase in HDL-cholesterol compared with control animals; non-HDL-cholesterol concentrations are not affected. In addition, Anacetrapib promotes reverse cholesterol transport from macrophages, and leads to a 30% increase in fecal cholesterol content. HDL from Anacetrapib-treated hamsters reveals an increase in SR-B1- and ABCG1-mediated efflux compared with controls. After oral administration of Anacetrapib at 10 mg/kg, ∼80 and 90% of the radioactive dose is recovered over 48 hous postdose from rats and monkeys, respectively. The majority of the administered radioactive dose is excreted unchanged in feces in both species.
研究领域
研究领域
CancerCancer MetabolismMetabolic signaling pathwayMetabolism of lipids and lipoproteins
CardiovascularAtherosclerosisLipid transport
CardiovascularLipids / LipoproteinsLipid MetabolismCholesterol Metabolism
MetabolismTypes of diseaseHeart disease
MetabolismPathways and ProcessesMetabolic signaling pathwaysLipid and lipoprotein metabolismCholesterol Metabolism
MetabolismPathways and ProcessesMetabolic signaling pathwaysLipid and lipoprotein metabolismLipid metabolism
Drug DiscoverySmall Molecule DrugLead Compound Discovery
Anacetrapib 875446-37-0温馨提示:本产品仅作科研实验使用,不支持临床等研究

产品咨询

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7
爱必信(上海)生物科技有限公司
地址:上海市浦东新区新浩路58号申江科创园18栋
邮箱:lanwu@univ-bio.com
传真:
关注我们
欢迎您关注我们的微信公众号了解更多信息:
欢迎您关注我们的微信公众号
了解更多信息